96 related articles for article (PubMed ID: 9117433)
1. Do low vancomycine serum levels predict failures of vancomycine therapy in neutropenic cancer patients?
Netriová J; Hal'ko J; Studená-Mrázová M; Kukucková E; Stopková K; Kral'ovicová K; Demitrovicová A; Grausová S; Krupová I; Trupl J; Krcméry V
Bratisl Lek Listy; 1996 Nov; 97(11):680-3. PubMed ID: 9117433
[TBL] [Abstract][Full Text] [Related]
2. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
Kralovicová K; Spanik S; Halko J; Netriova J; Studena-Mrazova M; Novotny J; Grausova S; Koren P; Krupova I; Demitrovicova A; Kukuckova E; Krcmery V
J Chemother; 1997 Dec; 9(6):420-6. PubMed ID: 9491842
[TBL] [Abstract][Full Text] [Related]
3. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
4. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
5. Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.
Dompeling EC; Donnelly JP; Deresinski SC; Feld R; Lane-Allman EF; De Pauw BE
Eur J Cancer; 1996 Jul; 32A(8):1332-9. PubMed ID: 8869095
[TBL] [Abstract][Full Text] [Related]
6. Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute.
Fanourgiakis P; Georgala A; Vekemans M; Daneau D; Heymans C; Aoun M
Clin Microbiol Infect; 2003 Oct; 9(10):1068-72. PubMed ID: 14616756
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
[TBL] [Abstract][Full Text] [Related]
9. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
[TBL] [Abstract][Full Text] [Related]
10. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
11. Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
D'Antonio D; Staniscia T; Piccolomini R; Fioritoni G; Rotolo S; Parruti G; Di Bonaventura G; Manna A; Savini V; Fiorilli MP; Di Giovanni P; Francione A; Schioppa F; Romano F
Chemotherapy; 2004 Jun; 50(2):81-7. PubMed ID: 15211082
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.
Elting LS; Rubenstein EB; Rolston KV; Bodey GP
Clin Infect Dis; 1997 Aug; 25(2):247-59. PubMed ID: 9332520
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
[TBL] [Abstract][Full Text] [Related]
15. Empiric use of vancomycin in the febrile neutropenic patient.
Cohen J
J Infect Dis; 1992 Mar; 165(3):591. PubMed ID: 1538168
[No Abstract] [Full Text] [Related]
16. Management of gram-positive coccal bacteremia and hemodialysis.
Fitzgibbons LN; Puls DL; Mackay K; Forrest GN
Am J Kidney Dis; 2011 Apr; 57(4):624-40. PubMed ID: 21333430
[TBL] [Abstract][Full Text] [Related]
17. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children.
Henwick S; Koehler M; Patrick CC
Clin Infect Dis; 1993 Oct; 17(4):667-71. PubMed ID: 8268348
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer.
Safdar A; Rolston KV
Cancer; 2006 Apr; 106(8):1815-20. PubMed ID: 16534785
[TBL] [Abstract][Full Text] [Related]
19. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
20. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.
Zimmermann AE; Katona BG; Plaisance KI
Pharmacotherapy; 1995; 15(1):85-91. PubMed ID: 7739950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
